Cancer News and Research

Latest Cancer News and Research

Unexpected link between muscular dystrophy and muscle wasting associated with cancer

A new study provides important insight into the mechanisms of a muscle wasting disorder that interferes with treatment for cancer and has a negative impact on patient survival.

5 Dec 2005

HRAS mutation analysis in Costello Syndrome

Gene mutations in the HRAS sequence are present in most patients affected with Costello syndrome, according to a new study in the American Journal of Medical Genetics. The mutations occurred de novo in patients, meaning, they were not observed in their parents' genes.

5 Dec 2005

Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease

Scientists at the Johns Hopkins Kimmel Cancer Center have found that a gene pathway linked to a deadly form of leukemia may provide a new way to treat autoimmune diseases, including multiple sclerosis.

2 Dec 2005

Drinking lots of coffee and tea can reduce the risk of chronic liver disease

A study published in the American Gastroenterological Association (AGA) journal Gastroenterology found that people at high risk for liver injury may be able to reduce their risk for developing chronic liver disease significantly by drinking more than two cups of coffee or tea daily.

2 Dec 2005

Bisphenol A (BPA) has been linked to damage in developing brain tissue

The chemical bisphenol A (BPA), widely used in products such as food cans, milk container linings, water pipes and even dental sealants, has now been found to disrupt important effects of estrogen in the developing brain.

2 Dec 2005

Herceptin - can healthcare afford this expensive drug?

New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.

2 Dec 2005

Breast CT may be better than mammography at detecting breast lesions

Breast CT, an investigational technology for early breast cancer detection, may be better than mammography at detecting breast lesions and is much more comfortable for women, researchers from the University of California, Davis reported at the annual meeting of the Radiological Society of North America in Chicago.

2 Dec 2005

Treatment of breast cancer in pregnancy

"The treatment of breast cancer when the patient is pregnant does not increase the risk of congenital anomalies", assures Dr. Guillermo Lopez, director of the Department of Gynaecology and Obstetrics at the University Hospital of the University of Navarra.

30 Nov 2005

Bacterial DNA and IVF contamination risk on New Scientist

Some children conceived by a common method of IVF could be carrying chunks of bacterial DNA in their chromosomes, according to a study in mice. The researchers who conducted the work say that such accidental genetic modification would be very rare, but they argue that fertility doctors should take more precautions to exclude it.

30 Nov 2005

University of Nottingham academic awarded prestigious professorship for research into lung disease

An academic at The University of Nottingham has been awarded a unique professorship by a leading national charity in recognition of his research, which aims to improve the medical care of patients with lung disease and respiratory infections.

30 Nov 2005

French woman has worlds' first face transplant

The operation apparently lasted several hours where tissues, muscles, arteries and veins were taken from a brain-dead donor and attached to the patient's lower face.

30 Nov 2005

Difficult decisions ahead over Herceptin breast cancer drug

According to Belgian researchers a drug prescribed for women with advanced breast cancer would be cost-effective for treating some, but not all patients, in the early stages of the disease.

30 Nov 2005

Warning that breast cancer drug can harm fetus

Health Canada along with drug company Novartis Pharmaceuticals Canada, have issued a warning concerning the drug Femara (letrozole), which is used to treat breast cancer in women who are postmenopausal.

30 Nov 2005

Hard to quit smoking even after cancer is diagnosed

According to a new study many people with cancer continue to smoke after their diagnosis, even though they are told that smoking can significantly compromise the outcome of any treatment.

29 Nov 2005

Pancreatic cancer and ecoendoscopy

Cancer of the pancreas is the number five in the list of deaths due to cancers in Spain and the third causing deaths due to digestive tumour.

28 Nov 2005

One-half of cancer patients continue to smoke after diagnosis

A pair of articles from The University of Texas M. D. Anderson Cancer Center makes the case that patients would receive better care if physicians and researchers would address the issue of tobacco use after a cancer diagnosis and monitor tobacco use during clinical trials that test new agents.

28 Nov 2005

Chemical found in plants helps prevent lung cancer

According to the results of an animal study, it is suggested that treatment with a chemical found in various plants, may help prevent lung cancer caused by cigarette smoking.

28 Nov 2005

Smoking cessation in cancer patients

A new report says despite a growing body of evidence that continued smoking after a cancer diagnosis has substantial adverse effects on treatment effectiveness, overall survival, risk of other cancers, and quality of life, up to one-half of cancer patients who smoke continue to do so or relapse after trying to quit.

28 Nov 2005

MRI to detect magnetic probes of tiny iron oxide particles successfully tracks implanted cells in cancer patients

By using MRI to detect magnetic probes of tiny iron oxide particles, an international research team for the first time has successfully tracked immune-stimulating cells implanted into cancer patients for treatment purposes.

28 Nov 2005

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

Duke University researchers have now shown that selectively killing the population of regulatory T cells in cancer patients - cells that normally function to restrain the activity of the immune response - improves the ability of a cancer vaccine to stimulate tumor-specific T cells.

28 Nov 2005